PubMed

Comparison of a non-preserved 0.1% T-Gel eye gel (single dose unit) with a preserved 0.1% T-Gel eye gel (multidose) in ocular hypertension and glaucomatous patients.

Easty DL, Nemeth-Wasmer G, Vounatsos JP, Girard B, Besnainou N, Pouliquen P, Delval L, Rouland JF.

Br J Ophthalmol. 2006 May;90(5):574-8.PMID: 16622086 [PubMed - indexed for MEDLINE]Related articlesFree article

A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.

Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.

Clin Ther. 2006 Mar;28(3):332-9.PMID: 16750448 [PubMed - indexed for MEDLINE]Related articles

A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.

Boyle JE, Ghosh K, Gieser DK, Adamsons IA.

Ophthalmology. 1998 Oct;105(10):1945-51.PMID: 9787368 [PubMed - indexed for MEDLINE]Related articles

A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.

Boyle JE, Ghosh K, Gieser DK, Adamsons IA.

Ophthalmology. 1999 Dec;106(12 Suppl):10-6.PMID: 10598692 [PubMed - indexed for MEDLINE]Related articles

24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.

Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM; Bimatoprost Circadian IOP Study Group.

Surv Ophthalmol. 2004 Mar;49 Suppl 1:S26-35.PMID: 15016559 [PubMed - indexed for MEDLINE]Related articles

A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.

Reis R, Queiroz CF, Santos LC, Avila MP, Magacho L.

Clin Ther. 2006 Apr;28(4):552-9.PMID: 16750466 [PubMed - indexed for MEDLINE]Related articles

Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.

Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.

Ann Pharmacother. 2008 Apr;42(4):498-504. Epub 2008 Mar 25.PMID: 18364402 [PubMed - indexed for MEDLINE]Related articles

A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension.

Diestelhorst M, Larsson LI; European Latanoprost Fixed Combination Study Group.

Br J Ophthalmol. 2004 Feb;88(2):199-203.PMID: 14736774 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America.

Susanna R Jr, Sheu WP; Latin American Glaucoma Society.

Clin Ther. 2004 May;26(5):755-68.PMID: 15220019 [PubMed - indexed for MEDLINE]Related articles

Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapy.

Shin D.

Surv Ophthalmol. 2000 Jan;44 Suppl 2:S163-8.PMID: 10665519 [PubMed - indexed for MEDLINE]Related articles

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.PMID: 12795627 [PubMed - indexed for MEDLINE]Related articles

The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group.

Strohmaier K, Snyder E, DuBiner H, Adamsons I.

Ophthalmology. 1998 Oct;105(10):1936-44.PMID: 9787367 [PubMed - indexed for MEDLINE]Related articles

The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.

Diestelhorst M.

Graefes Arch Clin Exp Ophthalmol. 2000 May;238(5):433-9.PMID: 10901475 [PubMed - indexed for MEDLINE]Related articles

Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.

Schenker H, Maloney S, Liss C, Gormley G, Hartenbaum D.

Clin Ther. 1999 Jan;21(1):138-47.PMID: 10090431 [PubMed - indexed for MEDLINE]Related articles

A 12-month, multicenter, randomized, double-masked, parallel-group comparison of timolol-LA once daily and timolol maleate ophthalmic solution twice daily in the treatment of adults with glaucoma or ocular hypertension.

Mundorf TK, Ogawa T, Naka H, Novack GD, Crockett RS; US Istalol Study Group.

Clin Ther. 2004 Apr;26(4):541-51.PMID: 15189751 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study.

Shedden A, Laurence J, Tipping R; Timoptic-XE 0.5% Study Group.

Clin Ther. 2001 Mar;23(3):440-50.PMID: 11318078 [PubMed - indexed for MEDLINE]Related articles

Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece.

Petounis A, Mylopoulos N, Kandarakis A, Andreanos D, Dimitrakoulias N.

J Glaucoma. 2001 Aug;10(4):316-24.PMID: 11558817 [PubMed - indexed for MEDLINE]Related articles

Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.

Schuman JS.

Ophthalmology. 2000 Jun;107(6):1171-7.PMID: 10857839 [PubMed - indexed for MEDLINE]Related articles

Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.

Orengo-Nania S, Landry T, Von Tress M, Silver LH, Weiner A, Davis AA; Travoprost Study Group.

Am J Ophthalmol. 2001 Dec;132(6):860-8.PMID: 11730649 [PubMed - indexed for MEDLINE]Related articles

Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study.

Schenker HI, Silver LH.

Am J Ophthalmol. 2000 Aug;130(2):145-50.PMID: 11004287 [PubMed - indexed for MEDLINE]Related articles